Irritable Bowel Syndrome affects an estimated one out of ten people in the US, yet the causes for this disease are multivariate and often unknown from case to case, creating a reputation in practice as a "waste basket diagnosis." Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has been a pioneer in helping clinicians better understand one potential cause of IBS. His own experience as IBS patient led to the remarkable discovery of an allergic contact enteritits underscoring his disease, which has led to new diagnostic and treatment algorithms for IBS patients nationwide. Dr. Stierstorfer joins Dr. Brian McDonough to discuss this unexpected path toward discovery and subsequent career specialization.
Irritable Bowel Syndrome and Type IV Allergies: Making the Connection in Practice

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Irritable Bowel Syndrome affects an estimated one out of ten people in the US, yet the causes for this disease are multivariate and often unknown from case to case, creating a reputation in practice as a "waste basket diagnosis." Dr. Michael Stierstorfer, Clinical Associate Professor of Dermatology at the University of Pennsylvania School of Medicine and founder of East Penn Dermatology, has been a pioneer in helping clinicians better understand one potential cause of IBS. His own experience as IBS patient led to the remarkable discovery of an allergic contact enteritits underscoring his disease, which has led to new diagnostic and treatment algorithms for IBS patients nationwide. Dr. Stierstorfer joins Dr. Brian McDonough to discuss this unexpected path toward discovery and subsequent career specialization.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?